All articles

Policy Issue 4

Policy

Read all articles from Edition 4 of the ESMO Perspectives.

Read more
telemedicine
Innovation

Telemedicine: the good and bad of living a hype

New forms of remote cancer care services have been piloted since the COVID-19 outbreak to offer support to patients while complying with hospital visiting restrictions. Despite a renewed popularity of telemedicine, digital services implemented so quickly may increase the risk of unmet expectations in the future.
Read more
Research_laboratory
Research

What role for real-world evidence in cancer research?

With the growing use of real-world evidence (RWE) to support regulatory approvals of new anti-cancer medicines in Europe and the USA, can this type of research ensure greater inclusion of women, the elderly, diverse ethnic groups, those with rare cancers and other under-represented populations in oncology studies?

Read more
Real world evidence
Clinical practice

Should we invest more in registry data?

During the COVID-19 pandemic, real-world data have shown they can support clinical decision-making in complex situations but extensive bureaucracy is still a limiting factor

Read more
Prevention_ribbon
Specialised education

Prevention and early detection are pivotal in LMICs, but not enough

While locally tailored cancer screening programmes, particularly for cervical cancer, are showing encouraging results in some areas with limited resources, cancer care is still suffering some bottlenecks due to lack of training for healthcare staff and shortages of medicines

Read more
Immuno oncology
Innovation

Cancer vaccination: a new era of innovation

Promising results with cancer vaccines based on specific antigen mutations in individual tumours, and typically used in combination with checkpoint inhibitors, are fuelling an upsurge of interest in cancer vaccination for patients with established cancer, explains Prof. Pedro Romero. 

Read more
Clinical practice

HER2+ breast cancer: from no hope to good prognosis in 20 years

Trastuzumab has transformed the prognosis for women with HER2+ breast cancer. On the occasion of the ESMO Breast Cancer Virtual Congress 2021, leading oncology experts recall with enthusiasm the pioneering work of researchers like José Baselga in this field and push for continuous research to investigate how to further improve the treatment of this cancer sub-type

Read more

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.